News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
747,680 Results
Type
Article (44095)
Company Profile (312)
Press Release (703253)
Multimedia
Podcasts (127)
Webinars (22)
Section
Business (211153)
Career Advice (2112)
Deals (36790)
Drug Delivery (140)
Drug Development (83528)
Employer Resources (176)
FDA (16891)
Job Trends (15527)
News (357717)
Policy (34150)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2637)
Accelerated approval (43)
Adcomms (27)
Allergies (170)
Alliances (51589)
ALS (200)
Alzheimer's disease (1776)
Antibody-drug conjugate (ADC) (406)
Approvals (17226)
Artificial intelligence (636)
Autoimmune disease (239)
Automation (52)
Bankruptcy (373)
Best Places to Work (11771)
BIOSECURE Act (21)
Biosimilars (214)
Biotechnology (187)
Bladder cancer (179)
Brain cancer (70)
Breast cancer (705)
Cancer (5523)
Cardiovascular disease (468)
Career advice (1796)
Career pathing (42)
CAR-T (309)
CDC (57)
Celiac Disease (2)
Cell therapy (824)
Cervical cancer (43)
Clinical research (71965)
Collaboration (2023)
Company closure (4)
Compensation (1313)
Complete response letters (82)
COVID-19 (2804)
CRISPR (107)
C-suite (1054)
Cystic fibrosis (154)
Data (7257)
Decentralized trials (3)
Denatured (37)
Depression (157)
Dermatology (69)
Diabetes (559)
Diagnostics (6948)
Digital health (53)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (313)
Drug pricing (214)
Drug shortages (34)
Duchenne muscular dystrophy (270)
Earnings (92944)
Editorial (64)
Employer branding (21)
Employer resources (155)
Events (121605)
Executive appointments (1076)
FDA (20436)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (32)
Funding (1666)
Gene editing (222)
Generative AI (57)
Gene therapy (680)
GLP-1 (1074)
Government (4852)
Grass and pollen (7)
Guidances (401)
Healthcare (19145)
HIV (76)
Huntington's disease (53)
IgA nephropathy (95)
Immunology and inflammation (289)
Immuno-oncology (87)
Indications (164)
Infectious disease (3131)
Inflammatory bowel disease (210)
Inflation Reduction Act (14)
Influenza (132)
Intellectual property (282)
Interviews (327)
IPO (16931)
IRA (57)
Job creations (4073)
Job search strategy (1500)
JPM (65)
Kidney cancer (18)
Labor market (94)
Layoffs (585)
Leadership (37)
Legal (8425)
Liver cancer (99)
Longevity (30)
Lung cancer (737)
Lymphoma (414)
Machine learning (55)
Management (60)
Manufacturing (987)
MASH (184)
Medical device (13963)
Medtech (14045)
Mergers & acquisitions (21042)
Metabolic disorders (1465)
mRNA (190)
Multiple sclerosis (177)
NASH (18)
Neurodegenerative disease (392)
Neuropsychiatric disorders (101)
Neuroscience (3224)
Neurotech (1)
NextGen: Class of 2026 (6647)
Non-profit (4574)
Now hiring (74)
Obesity (696)
Opinion (305)
Ovarian cancer (197)
Pain (253)
Pancreatic cancer (266)
Parkinson's disease (347)
Partnered (34)
Patents (571)
Patient recruitment (621)
Peanut (63)
People (61400)
Pharmaceutical (85)
Pharmacy benefit managers (34)
Phase 1 (22331)
Phase 2 (31658)
Phase 3 (23698)
Pipeline (7508)
Policy (324)
Postmarket research (2657)
Preclinical (9498)
Press Release (68)
Prostate cancer (283)
Psychedelics (51)
Radiopharmaceuticals (319)
Rare diseases (1039)
Real estate (6312)
Recruiting (72)
Regulatory (25986)
Reports (55)
Research institute (2459)
Resumes & cover letters (362)
Rett syndrome (33)
RNA editing (20)
RSV (87)
Schizophrenia (176)
Series A (277)
Series B (208)
Service/supplier (11)
Sickle cell disease (110)
Special edition (25)
Spinal muscular atrophy (167)
Sponsored (46)
Startups (3778)
State (2)
Stomach cancer (19)
Supply chain (129)
Tariffs (99)
The Weekly (88)
Vaccines (1095)
Venture capital (101)
Weight loss (456)
Women's health (115)
Worklife (20)
Date
Today (159)
Last 7 days (615)
Last 30 days (2678)
Last 365 days (30638)
2026 (9217)
2025 (30679)
2024 (35763)
2023 (40629)
2022 (51799)
2021 (56329)
2020 (54791)
2019 (47398)
2018 (35771)
2017 (33136)
2016 (32667)
2015 (38631)
2014 (32540)
2013 (27656)
2012 (29748)
2011 (30497)
2010 (28504)
Location
Africa (803)
Alabama (91)
Alaska (7)
Arizona (342)
Arkansas (16)
Asia (42453)
Australia (6809)
California (12534)
Canada (3605)
China (1297)
Colorado (538)
Connecticut (543)
Delaware (379)
Europe (91245)
Florida (1891)
Georgia (402)
Hawaii (3)
Idaho (62)
Illinois (1011)
India (87)
Indiana (585)
Iowa (22)
Japan (517)
Kansas (130)
Kentucky (46)
Louisiana (40)
Maine (75)
Maryland (1513)
Massachusetts (9004)
Michigan (352)
Minnesota (690)
Mississippi (6)
Missouri (142)
Montana (33)
Nebraska (29)
Nevada (138)
New Hampshire (83)
New Jersey (3341)
New Mexico (29)
New York (3314)
North Carolina (1608)
North Dakota (8)
Northern California (6205)
Ohio (375)
Oklahoma (24)
Oregon (46)
Pennsylvania (2545)
Puerto Rico (28)
Rhode Island (50)
South America (1179)
South Carolina (83)
South Dakota (2)
Southern California (4935)
Tennessee (201)
Texas (1986)
United States (44567)
Utah (379)
Vermont (1)
Virginia (311)
Washington D.C. (80)
Washington State (1012)
West Virginia (4)
Wisconsin (127)
Wyoming (2)
747,680 Results for "arrowhead pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arrowhead Pharmaceuticals to Participate in Upcoming March 2026 Events
February 24, 2026
·
4 min read
Weight Loss
Arrowhead Enters Obesity Chat by Doubling Tirzepatide’s Weight Loss in Combo Study
Arrowhead heralded the results as proof of concept that inhibiting the Activin E pathway can improve body composition and enhance weight loss as compared to tirzepatide alone, particularly in patients with type 2 diabetes.
January 6, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Arrowhead Pharmaceuticals Reports Fiscal 2026 First Quarter Results
February 6, 2026
·
12 min read
Press Releases
Arrowhead Pharmaceuticals to Webcast Fiscal 2026 First Quarter Results
January 21, 2026
·
4 min read
Press Releases
Arrowhead Pharmaceuticals to Participate in Upcoming January 2026 Events
December 24, 2025
·
4 min read
Approvals
Arrowhead Secures Maiden Approval, First FDA Nod for Rare Genetic Metabolic Disorder
The FDA approval of the siRNA drug Redemplo caps off a tumultuous 12 months for Arrowhead, whose partnership with Sarepta caused its own stock to drop during the gene therapy maker’s safety troubles this summer.
November 18, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Arrowhead Pharmaceuticals Announces Proposed Offerings of Convertible Senior Notes and Common Stock
January 7, 2026
·
8 min read
Press Releases
Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology’s 75th Annual Scientific Session and Expo
March 30, 2026
·
10 min read
Press Releases
Arrowhead Pharmaceuticals to Participate in Upcoming December 2025 Conferences
December 2, 2025
·
4 min read
C-suite
Caught In Sarepta ‘Downdraft,’ Arrowhead Becomes RNAi Knight in Shining Armor
Sarepta’s troubles had nothing to do with Arrowhead’s assets, and yet both companies have seen their stock prices decline this past month.
BioSpace
caught up with Arrowhead’s Chris Anzalone to talk about the biotech’s role as an RNAi pipeline savior.
August 12, 2025
·
7 min read
·
Annalee Armstrong
1 of 74,768
Next
